Open Label Extension study of Rozanolixizumab in CIDP
Clinical Trial Grant
Administered By
Neurology, Neuromuscular Disease
Awarded By
UCB Biopharma SPRL
Start Date
December 7, 2020
End Date
September 6, 2022
Administered By
Neurology, Neuromuscular Disease
Awarded By
UCB Biopharma SPRL
Start Date
December 7, 2020
End Date
September 6, 2022